Cargando…
011 Systemic hyperinflammation as a driver of maculopapular drug exanthema in severely ill COVID-19 patients?
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053927/ http://dx.doi.org/10.1016/j.jid.2021.02.027 |
| _version_ | 1783680217103990784 |
|---|---|
| author | Mitamura, Y. Schulz, D. Kolm, I. Oro, S. Levesque, M. Maverakis, E. Akdis, C. Brüggen, M. |
| author_facet | Mitamura, Y. Schulz, D. Kolm, I. Oro, S. Levesque, M. Maverakis, E. Akdis, C. Brüggen, M. |
| author_sort | Mitamura, Y. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8053927 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80539272021-04-19 011 Systemic hyperinflammation as a driver of maculopapular drug exanthema in severely ill COVID-19 patients? Mitamura, Y. Schulz, D. Kolm, I. Oro, S. Levesque, M. Maverakis, E. Akdis, C. Brüggen, M. J Invest Dermatol Adaptive and Auto-Immunity Published by Elsevier Inc. 2021-05 2021-04-19 /pmc/articles/PMC8053927/ http://dx.doi.org/10.1016/j.jid.2021.02.027 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Adaptive and Auto-Immunity Mitamura, Y. Schulz, D. Kolm, I. Oro, S. Levesque, M. Maverakis, E. Akdis, C. Brüggen, M. 011 Systemic hyperinflammation as a driver of maculopapular drug exanthema in severely ill COVID-19 patients? |
| title | 011 Systemic hyperinflammation as a driver of maculopapular drug exanthema in severely ill COVID-19 patients? |
| title_full | 011 Systemic hyperinflammation as a driver of maculopapular drug exanthema in severely ill COVID-19 patients? |
| title_fullStr | 011 Systemic hyperinflammation as a driver of maculopapular drug exanthema in severely ill COVID-19 patients? |
| title_full_unstemmed | 011 Systemic hyperinflammation as a driver of maculopapular drug exanthema in severely ill COVID-19 patients? |
| title_short | 011 Systemic hyperinflammation as a driver of maculopapular drug exanthema in severely ill COVID-19 patients? |
| title_sort | 011 systemic hyperinflammation as a driver of maculopapular drug exanthema in severely ill covid-19 patients? |
| topic | Adaptive and Auto-Immunity |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053927/ http://dx.doi.org/10.1016/j.jid.2021.02.027 |
| work_keys_str_mv | AT mitamuray 011systemichyperinflammationasadriverofmaculopapulardrugexanthemainseverelyillcovid19patients AT schulzd 011systemichyperinflammationasadriverofmaculopapulardrugexanthemainseverelyillcovid19patients AT kolmi 011systemichyperinflammationasadriverofmaculopapulardrugexanthemainseverelyillcovid19patients AT oros 011systemichyperinflammationasadriverofmaculopapulardrugexanthemainseverelyillcovid19patients AT levesquem 011systemichyperinflammationasadriverofmaculopapulardrugexanthemainseverelyillcovid19patients AT maverakise 011systemichyperinflammationasadriverofmaculopapulardrugexanthemainseverelyillcovid19patients AT akdisc 011systemichyperinflammationasadriverofmaculopapulardrugexanthemainseverelyillcovid19patients AT bruggenm 011systemichyperinflammationasadriverofmaculopapulardrugexanthemainseverelyillcovid19patients |